Sale!

SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test

Original price was: R9,350.Current price is: R6,700.

-28%

Facing concerns about your infant’s seizures or developmental delays? Our SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test provides the answers you need for peace of mind. Using advanced next-generation sequencing technology, this comprehensive test accurately identifies mutations in the SCN2A gene that cause severe epilepsy in infants. For only ZAR 6,700 (regularly ZAR 9,350), you’ll receive precise results within 3-4 weeks, helping your healthcare team develop targeted treatment strategies. The test includes essential genetic counselling to help you understand your family’s risk factors and create a personalised care plan. Available nationwide across South Africa, including Johannesburg, Cape Town, and Durban, our trusted testing service gives you the clarity needed to make informed decisions about your child’s neurological health and future development.

📞 24/7 South African Support Team Call : +27 6412 56421

  • ✓ ISO Accredited Lab Reports
  • ✓ Free Genetic Counseling Included
  • 🔒 100% Confidential & Secure Testing
Guaranteed Safe Checkout

SCN2A Gene Epilepsy Test ZAR 6
SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test
R9,350 Original price was: R9,350.R6,700Current price is: R6,700.

[wpforms id=”1190″ title=”true” description=”Request a call back”]

Find Answers for Your Infant’s Seizures with SCN2A Gene Testing

When your baby experiences unexplained seizures or developmental delays, the uncertainty can be overwhelming. Our SCN2A Gene Early Infantile Epileptic Encephalopathy Type 11 NGS Genetic DNA Test provides the clarity and answers South African families need during this challenging time. Using cutting-edge next-generation sequencing technology, we deliver accurate, reliable results that help guide your child’s treatment journey.

Understanding the SCN2A Gene Test

The SCN2A gene plays a crucial role in brain function, and mutations in this gene can cause Early Infantile Epileptic Encephalopathy Type 11 – a severe form of epilepsy that begins in the first months of life. Our advanced NGS (Next-Generation Sequencing) technology examines the SCN2A gene with exceptional precision, identifying even the smallest genetic variations that could be affecting your child’s neurological health.

This isn’t just a test – it’s a pathway to understanding. By identifying the specific genetic cause of your infant’s condition, healthcare providers can develop more targeted treatment approaches that may improve seizure control and developmental outcomes.

Who Should Consider This Test?

This test is particularly important for infants and families experiencing:

  • Unexplained seizures beginning in the first 3 months of life
  • Developmental delays or regression following seizure onset
  • Abnormal EEG patterns without clear cause
  • Family history of infantile epilepsy or neurological disorders
  • Resistance to standard anti-epileptic medications
  • Concerns about future developmental milestones

If your child’s healthcare team has mentioned the possibility of a genetic epilepsy syndrome, this test provides the definitive answers needed for proper diagnosis and management.

Why Early Genetic Testing Matters for Your Child’s Health

Getting an accurate genetic diagnosis through our SCN2A test offers multiple life-changing benefits:

  • Targeted Treatment: Specific genetic findings can guide medication choices that may be more effective for SCN2A-related epilepsy
  • Developmental Planning: Understanding the genetic basis helps anticipate and address potential developmental challenges
  • Family Planning: Genetic counselling provides insight into recurrence risks for future pregnancies
  • Reduced Diagnostic Uncertainty: End the cycle of multiple tests and uncertain diagnoses
  • Access to Support: Connect with specialised resources and support networks for genetic epilepsy conditions

Understanding Your Test Results

We understand that waiting for genetic test results can be anxiety-provoking. Our comprehensive reporting includes:

  • Clear, easy-to-understand explanation of findings
  • Detailed interpretation by our expert genetic specialists
  • Personalised recommendations for next steps in care
  • Genetic counselling session to discuss results and implications
  • Connection to appropriate medical specialists if needed

Your results will be thoroughly explained during your genetic counselling session, ensuring you have all the information needed to make informed decisions about your child’s care.

Transparent Pricing – Special Offer for South African Families

Service Regular Price Special Price Savings
SCN2A Gene NGS Test ZAR 9,350 ZAR 6,700 ZAR 2,650
Genetic Counselling Session INCLUDED
Family Pedigree Analysis INCLUDED
Results Interpretation INCLUDED

Price includes all laboratory fees, genetic counselling, and comprehensive reporting. No hidden costs.

Why Trust Oracle Genomics?

As South Africa’s leading genetic testing provider, we combine medical excellence with compassionate care:

  • Nationwide Coverage: Available in Johannesburg, Cape Town, Durban, Pretoria and across South Africa
  • Expert Team: Board-certified genetic specialists and neurologists
  • Advanced Technology: State-of-the-art NGS sequencing for maximum accuracy
  • Rapid Turnaround: Results in 3-4 weeks – faster than many international labs
  • Comprehensive Support: From initial consultation through results interpretation
  • Multiple Sample Options: Blood, extracted DNA, or simple FTA card blood spot

Take the First Step Toward Answers Today

Don’t let uncertainty about your infant’s health create unnecessary stress. Early genetic testing can provide the clarity needed to optimise your child’s treatment and development.

Limited Time Offer: This special pricing of ZAR 6,700 (regularly ZAR 9,350) won’t last forever. Secure your child’s genetic testing today and take control of their neurological health journey.

“The clarity we gained from genetic testing helped us find the right treatment approach for our daughter. We finally had answers after months of uncertainty.” – Johannesburg Parent